1962
M. Crespo, E. Evangelio / Journal of Organometallic Chemistry 689 (2004) 1956–1964
3
4
3
[td, J(H–H) ¼ 6.5, J(H–H) ¼ 1.5, H6], 8.03 [dd, J(H–
127.2, 127.9, 130.11, CHAr}, {128.44, 129.0, 130.4,
130.7, 131.1, CAr}, 161.0 [2J(Pt–C) ¼ 92, Cf ]. 195Pt NMR
(54 MHz, CDCl3): d ¼ ꢀ3432 [s]. MS-FAB (+) (NBA,
m=z): 486 [M–Me]þ, 471 [M–2Me]þ. Anal. Found: C,
49.9; H, 5.2; N, 5.5. Calc. for C21H26N2Pt: C, 50.29; H,
5.23; N, 5.59%.
H) ¼ 6.5, J(H–H) ¼ 1.5, H5], 8.04 [dd, J(H–H) ¼ 7.5,
4
3
4J(H–H) ¼ 1.5, H4], 8.50 [s, H10], 8.53 [dd, 3J(H–
H) ¼ 7.5, J(H–H) ¼ 1.5, H1], 8.55 [dd, J(H–H) ¼ 9.0,
4J(H–H) ¼ 1.5, H8], 9.46 [s, Hd]. 13C NMR (50 MHz,
CDCl3): d ¼ 45:8 [Ca], {60.0, 61.1, Cb, Cc}, {124.9 [2C],
125.1 [2C], 126.5 [2C], 128.7 [2C], 129.0 [C10], CHAr},
{123.5 [C9], 129.8 [2C], 131.2 [2C], CAr}, 161.0 [Cd]. MS-
CI (NH3, m=z): 277 [M + H]þ.
4
3
[PtMe2{9-(Me2NCH2CH2NCH)C14H9}] (3b). Yield:
137 mg (78%). 1H NMR (500 MHz, acetone-d6):
d ¼ ꢀ0:93 [s, J(Pt–H) ¼ 93, Mea], 0.19 [s, J(Pt–H) ¼
86, Meb], 2.80 [s, 3J(Pt–H) ¼ 20, Hc], 3.00 [t, 3J(H–
H) ¼ 6.0, Hd], 4.41 [td, 3J(H–H) ¼ 6.0, He], 7.49 [t, 3J(H–
H) ¼ 7.0, 4J(H–H) ¼ 1.0, H2], 7.50 [td, 3J(H–H) ¼ 7.0,
4J(H–H) ¼ 1.0, H3], 7.54 [td, 3J(H–H) ¼ 9.0, 4J(H–
H) ¼ 1.0, H7], 7.55 [td, 3J(H–H) ¼ 6.0, 4J(H–H) ¼ 1.0,
2
2
9-(C6H5CH2N@CH)C14H9 (2c) was obtained as a
white solid from of phenanthrene-9-aldehyde (500 mg,
2.42 mmol) and the equimolar amount (260 mg) of
benzylamine using an analogous procedure than for 2a
and 2b. Yield: 530 mg (74%). IR: m(CH@N) ¼ 1641
cmꢀ1. H NMR (200 MHz, CDCl3): d ¼ 4:96 [s, Ha],
H6], 8.08 [dd, J(H–H) ¼ 6.0, J(H–H) ¼ 1.0, H5], 8.10
1
3
4
3
3
4
3
{7.20–7.50 [m, 5H], 7.59–7.77 [m, 4H], 7.92 [dd, J(H–
[dd, J(H–H) ¼ 7.0, J(H–H) ¼ 1.0, H4], 8.30 [dd, J(H–
H) ¼ 7.0, 1H], 8.15 [s, H10], 8.62–8.74 [m, 2H], 9.09 [m,
1H], aromatics}, 9.02 [s, Hb]. 13C NMR (50 MHz,
CDCl3): d ¼ 66:1 [Ca], {122.5, 122.9, 125.3, 126.7, 126.8,
126.9, 126.8, 127.1, 127.9, 128.5, 129.4, 131.2, CHAr},
162.1 [Cb]. MS-CI (NH3, m=z): 296 [M + H]þ.
H) ¼ 7.0, J(H–H) ¼ 1.0, H1], 8.32 [dd, J(H–H) ¼ 9.0,
4J(H–H) ¼ 1.0, H8], 8.64 [s, H10], 10.12 [s, 3J(Pt–
H) ¼ 54, Hf ]. 13C NMR (62.5 MHz, CDCl3): d ¼ ꢀ26:6
[Mea], )17.6 [Meb], 48.8 [Cc], 65.9 [Cd], 66.0 [Ce], {125.7
[2C], 125.8 [2C], 126.0 [2C], 128.6 [C10], 128.8 [2C],
CHAr}, {126.7 [C9], 128.4 [2C], 131.7 [2C], CAr}, 161.5
[Cf ]. 195Pt NMR (54 MHz, CDCl3): d ¼ ꢀ3458 [s]. MS-
FAB (+) (NBA, m=z): 486 [M–Me]þ, 471 [M–2Me]þ.
Anal. Found: C, 48.6; H, 5.4; N, 5.4. Calc. for
C21H26N2Pt Æ H2O: C, 48.55; H, 5.43; N, 5.39%.
4
3
9-(C6H5CH2N@CH)C14H9 (2d) was obtained as a
yellow solid using the same procedure than for 2c from
anthracene-9-aldehyde. Yield: 600 mg (84%). IR:
m(CH@N) ¼ 1635 cmꢀ1. H NMR (200 MHz, CDCl3):
1
d ¼ 5:20 [s, Ha], {7.29–7.43 [m, 3H], 7.45–7.56 [m, 6H],
8.08–8.14 [m, 2H], 8.65 [s, 1H], 8.73–8.75 [m, 2H], aro-
matics}, 9.72 [s, Hb]. 13C NMR (50 MHz, CDCl3):
d ¼ 67.2 [Ca], {126.0 [2C], 126.2 [2C], 127.6 [2C], 127.8,
129.1 [2C], 129.4 [2C], 129.8 [2C], 130.4, CHAr}, {131.1
[2C], 132.4 [2C], 141.0, CAr}, 161.8 [Cb]. MS-CI (NH3,
m=z): 296 [M + H]þ.
Compounds 4a/4a0 and 4b were obtained by refluxing
during 2 h (4a/4a0) or 3 h (4b) a toluene solution (20 ml)
containing, respectively, 3a (118 mg, 0.24 mmol) or 3b
(95 mg, 0.2 mmol). The solvent was removed in a rotary
evaporator and the red residue was washed with ether
(3 · 2 ml) to yield light brown (4a/4a0) or dark red (4b)
solids which were dried in vacuum.
3.2.2. Synthetic procedure for the platinum compounds
Compounds 3 were obtained by adding a solution of
the corresponding imine (96 mg, 0.348 mmol) in acetone
(10 ml) to a solution of compound [Pt2Me4(l-SMe2)2]
(1) (100 mg, 0.174 mmol) in acetone (10 ml). The mix-
ture was stirred for 30 min at room temperature, and the
solvent was removed in a rotary evaporator. The yellow
(3a) or orange (3b) solids were washed with ether
(3 · 2 ml) and dried in vacuum. [PtMe2{9-(Me2NCH2-
CH2NCH)C14H9}] (3a). Yield: 157 mg (90%). 1H NMR
(500 MHz, acetone-d6): d ¼ ꢀ0:06 [s, 2J(Pt–H) ¼ 94,
Mea], 0.52 [s, 2J(Pt–H) ¼ 88, Meb], 2.95 [s, 3J(Pt–
[PtMe{9-(Me2NCH2CH2NCH)C14H8}] (4a/4a0). Yi-
1
eld: 90 mg (79%). H NMR (500 MHz): 4a ¼ 1.34 [s,
2J(Pt–H) ¼ 72, Mea], 2.74 [s, 3J(Pt–H) ¼ 14, Hb], 3.15 [t,
3J(H–H) ¼ 6.5, Hc], 4.02 [t, 3J(H–H) ¼ 5.5, Hd], 7.42 [dd,
4
3J(H–H) ¼ 8.0, J(H–H) ¼ 1.0, H7], 7.43–7.47 [m, H2],
7.55 [td, 3J(H–H) ¼ 7.5, 4J(H–H) ¼ 1.0, H3], 7.61 [td,
3J(H–H) ¼ 7.0, 4J(H–H) ¼ 1.0, H6], 8.47 [d, 3J(H–
H) ¼ 8.0, H4], 8.59 [d, 3J(H–H) ¼ 8.0, H5], 8.63 [d, 3J(H–
H) ¼ 8.0, H8], 8.91 [td, 3J(H–H) ¼ 7.0, H1], 9.43 [s,
3J(Pt–H) ¼ 59, He]. 4a0 d ¼ 0:91 [s, 2J(Pt–H) ¼ 77, Mea],
3
3
2.72 [t, J(H–H) ¼ 6.0, Hc], 2.80 [s, J(Pt–H) ¼ 18, Hb],
3
3.96 [t, J(H–H) ¼ 6.5, Hd], 7.35–7.45 [m, H3, H6], 7.78
H) ¼ 25, Hc], 2.98 [t, J(H–H) ¼ 6.0, Hd], 4.34 [t, J(H–
[s, H10], 7.81 [d, 3J(H–H) ¼ 7.5, H2], 7.92 [dd, 3J(H–
3
3
H) ¼ 6.0, He], 7.67 [td, 3J(H–H) ¼ 8.0, 4J(H–H) ¼ 1.0,
H) ¼ 8.5, J(H–H) ¼ 1.0, H1], 8.09 [dd, J(H–H) ¼ 7.5,
4
3
H2], 7.71 [td, J(H–H) ¼ 8.0, J(H–H) ¼ 1.0, H7], 7.73
4J(H–H) ¼ 1.0, H4], 8.35 [d, 3J(H–H) ¼ 8.0, H5], 8.53
3
4
3
4
3
3
4
3
[td, J(H–H) ¼ 8.0, J(H–H) ¼ 1.0, H6], 7.78 [td, J(H–
[dd, J(H–H) ¼ 8.8, J(H–H) ¼ 1.0, H7], 8.72 [s, J(Pt–
H) ¼ 8.0, 4J(H–H) ¼ 1.0, H3], 8.17 [d, 3J(H–H) ¼ 8.0,
H) ¼ 37, He]. 13C NMR (100 MHz, CDCl3): d ¼ 0:21
0
0
0
H1], 8.31 [dd, J(H–H) ¼ 8.0, J(H–H) ¼ 1.0, H8], 8.94
[Ca], 1.24 [Ca ], 48.6 [Cb], 49.4 [Cb0 ], 52.7 [Cc], 60.1 [Cc ],
3
4
0
0
3
3
4
[d, J(H–H) ¼ 8.0, H4], 9.01 [dd, J(H–H) ¼ 8.0, J(H–
65.2 [Cd ],0 68.6 [Cd], {119.2 [C5 ], 122.1 [m, C1 , C4],
0
H) ¼ 1.0, H5], 9.53 [s, H10], 10.04 [s, J(Pt–H) ¼ 49, Hf ].
122.8 [C10 ], 123.5–123.7 [4s, C8, C5, C7 , C1], 124.0,
3
13C NMR (62.5 MHz, CDCl3): d ¼ )24.8 [Ca, 1J(Pt–
125.6, 126.1, 126.7, 127.0,0 128.1 [C3], 128.7 [C6], 129.2
0
C) ¼ 1158], )18.4 [Cb, J(Pt–C) ¼ 912], 49.5 [Cc], {65.3,
[C2 ], CHAr}, 157.7 [s, Ce ], 165.2 [s, Ce]. 195Pt NMR
1
65.2, Cd, Ce}, {122.6, 123.4, 123.5, 126.8, 126.9, 127.0,
(54 MHz, CDCl3): d ¼ ꢀ3218 [s, 4a0], )3421 [s, 4a].